Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
1.790
-0.090 (-4.79%)
At close: Jan 30, 2026, 4:00 PM EST
1.800
+0.010 (0.56%)
After-hours: Jan 30, 2026, 7:41 PM EST
Acrivon Therapeutics Market Cap
Acrivon Therapeutics has a market cap or net worth of $56.48 million as of January 30, 2026. Its market cap has decreased by -67.25% in one year.
Market Cap
56.48M
Enterprise Value
-69.78M
1-Year Change
-67.25%
Ranking
Category
Stock Price
$1.79
Market Cap Chart
Since the IPO on November 15, 2022, Acrivon Therapeutics's market cap has decreased from $235.12M to $56.48M, a decrease of -75.98%. That is a compound annual growth rate of -35.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 56.48M | -25.73% |
| Dec 31, 2025 | 76.05M | -59.43% |
| Dec 31, 2024 | 187.44M | 71.66% |
| Dec 29, 2023 | 109.20M | -54.61% |
| Dec 30, 2022 | 240.59M | 2.33% |
| Nov 15, 2022 | 235.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tevogen Bio Holdings | 61.17M |
| InflaRx | 59.76M |
| Nutriband | 58.23M |
| TScan Therapeutics | 57.88M |
| Metagenomi Therapeutics | 57.82M |
| PMV Pharmaceuticals | 57.47M |
| Grace Therapeutics | 56.17M |
| MiNK Therapeutics | 55.30M |